Search DVA
DAVITA INC.
NYSE · CIK 927066
Last close178.69
Daily change+2.34 (1.33%)
10 Years gain+178.77%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
DVA · STANDARD
SIC 8090 · Services-Misc Health & Allied Services, NEC · Fiscal year end 1231
Fundamental
44.0Momentum
49.4Acceleration
49.4Confidence
72.0Annual Revenue10
Quarterly Revenue41
Annual CFO19
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth8.5 / 25
Quality18.8 / 25
Capital Efficiency0.0 / 20
Balance Sheet14.5 / 15
Shareholder Economics0.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 18.681%.
Key Metrics
Revenue Growth TTM8.04%OK
Revenue CAGR 3Y5.53%OK
Gross Marginn/aMISSING
Operating Margin15.28%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROICn/aMISSING
Incremental Operating Margin 3Y36.39%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-18.68%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $13.64B | n/a | $2.04B | $1.89B | $1.31B | n/a | 14.98% | 9.61% | n/a | 75.89M |
| 2025 FY Dec 31, 2024 | $12.82B | n/a | $2.09B | $2.02B | $1.47B | n/a | 16.31% | 11.44% | n/a | 87.27M |
| 2025 FY Dec 31, 2023 | $12.14B | n/a | $1.60B | $2.06B | $1.49B | n/a | 13.2% | 12.28% | 247.03% | 93.18M |
| 2024 FY Dec 31, 2022 | $11.61B | n/a | $1.34B | $1.56B | $961.14M | n/a | 11.53% | 8.28% | 321.69% | 95.83M |
| 2023 FY Dec 31, 2021 | $11.62B | n/a | $1.80B | $1.93B | $1.29B | n/a | 15.47% | 11.1% | 219.01% | 109.95M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $13.77B | sum latest 4 fiscal quarters Revenue | OK | 0000927066-26-000108, 0000927066-25-000165 |
| Revenue Growth TTM | 8.04% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000927066-26-000108, 0000927066-25-000165 |
| Revenue CAGR 3Y | 5.53% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000927066-26-000012 |
| Revenue CAGR 5Y | 3.39% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000927066-26-000012 |
| Gross Profit CAGR 3Y | n/a | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | INSUFFICIENT_HISTORY | derived |
| Operating Income Growth | 7.15% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0000927066-26-000108, 0000927066-25-000165 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Margin | 15.28% | Operating Income / Revenue | OK | 0000927066-26-000108, 0000927066-25-000165 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000927066-26-000108 |
| Current Ratio | 1.47x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $208.34 | Revenue / Diluted Shares | OK | 0000927066-26-000108, 0000927066-25-000165 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |
| Dividend Payout Ratio | n/a | Cash dividends paid / Net income | NOT_MEANINGFUL | 0000927066-26-000012 |
| Diluted EPS TTM | $12.29 | Net income TTM / Diluted shares | OK | 0000927066-26-000108, 0000927066-25-000165 |